Anpac Bio Announces Appointment of New Independent Director
November 16, 2020 16:01 ET
|
Anpac Bio, USA
SAN JOSE, Calif., Nov. 16, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
Global Liquid Biopsy Market 2020-2024 - Market is Poised to Grow by $4.02 Billion
November 11, 2020 04:48 ET
|
Research and Markets
Dublin, Nov. 11, 2020 (GLOBE NEWSWIRE) -- The "Global Liquid Biopsy Market 2020-2024" report has been added to ResearchAndMarkets.com's offering. The liquid biopsy market is poised to grow by $...
AnPac Bio US Completes COVID-19 Antibody Test Verification and Approved to Begin Commercial Testing
November 10, 2020 07:30 ET
|
Anpac Bio, USA
SAN JOSE, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
Anpac Bio Completes Over 200,000 Biophysics Based Cancer Detection Tests, With Data Covering Close to 60 Types of Cancer
October 26, 2020 06:45 ET
|
Anpac Bio, USA
SAN JOSE, Calif., Oct. 26, 2020 (GLOBE NEWSWIRE) -- Anpac Bio-Medical Science Co., Ltd. (“Anpac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in China and the United...
Insights into Companion Diagnostics During the COVID-19 Pandemic - 2020 Market Study
October 21, 2020 08:13 ET
|
Research and Markets
Dublin, Oct. 21, 2020 (GLOBE NEWSWIRE) -- The "Companion Diagnostics in the COVID-19 Era: Market Analysis and Opportunities" report has been added to ResearchAndMarkets.com's offering. This...
Global Liquid Biopsy Market to 2028: Opportunities in Existing Applicability in Non-Availability of Tissue Sections for Traditional Biopsy Approaches
October 09, 2020 05:39 ET
|
Research and Markets
Dublin, Oct. 09, 2020 (GLOBE NEWSWIRE) -- The "Global Liquid Biopsy Market: Focus on Market Segmentation by Product Type, by Indication Type, by Technology, by Biomarker, by Clinical Applications,...
AnPac Bio Announces Equity Investment from Keystone Capital Partners for up to $7 Million
October 01, 2020 07:30 ET
|
Anpac Bio, USA
SAN JOSE, Calif., Oct. 01, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
Liquid Biopsy Market, 2027
September 17, 2020 05:58 ET
|
Research and Markets
Dublin, Sept. 17, 2020 (GLOBE NEWSWIRE) -- The "Global Liquid Biopsy Market (by Circulating Biomarker, Product, Application, End User, Clinical Application, Cancer Types, Sample Type, Regional &...
AnPac Bio Receives Major Immunology Testing Contract
September 15, 2020 07:00 ET
|
Anpac Bio, USA
SAN JOSE, Calif., Sept. 15, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
North America $3.5 Billion Liquid Biopsy Market to 2027: Consistent Launch of New Products
September 10, 2020 10:48 ET
|
Research and Markets
Dublin, Sept. 10, 2020 (GLOBE NEWSWIRE) -- The "North America Liquid Biopsy Market to 2027 - Regional Analysis and Forecasts by Product & Services; Sample; Application; End User; and, Country"...